Albumin administration in acute ischemic stroke: Safety analysis of the ALIAS Part 2 Multicenter Trial

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Hill, Michael D ^a   Martin, Renee H ^b   Palesch, Yuko Y ^b   Moy, Claudia S ^c   Tamariz, Diego ^d   Ryckborst, Karla J ^e   Jones, Elizabeth B ^f   Weisman, David ^g   Pettigrew, Creed ^h   Ginsberg, Myron D ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g Abington Pediat Neurologic Consult   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIURETIC AGENT; INFUSION FLUID; PLACEBO; SODIUM CHLORIDE; TROPONIN; ALBUMINOID; NEUROPROTECTIVE AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CANADA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FINLAND; HUMAN; ISRAEL; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VERY ELDERLY; CHEMICALLY INDUCED; CLINICAL TRIAL; HEART FAILURE; MULTICENTER STUDY; STROKE;

ACUTE CORONARY SYNDROME; AGED; ALBUMINS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; HEART FAILURE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; PULMONARY EDEMA; PULMONARY EMBOLISM; STROKE;

EID: 84943311719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131390     Document Type: Article

References (28)

1. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke. 2001;32(2):553-60. PMID: 11157196.
2. Ginsberg M, Belayev L, Bazan N, Marcheselli V, Hill M, Palesch Y, et al. Albumin-based neurotherapeutics for acute ischemic stroke: from bench to bedside. In: J K, S K, editors. Pharmacology of Cerebral Ischemia. Stuttgart: Medpharm Scientific Publishers; 2004. p. 421-33.
3. Belayev L, Zhao W, Pattany PM, Weaver RG, Huh PW, Lin B, et al. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke. 1998;29(12):2587-99. PMID: 9836772.
4. Belayev L, Pinard E, Nallet H, Seylaz J, Liu Y, Riyamongkol P, et al. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke. 2002;33(4):1077-84. PMID: 11935064.
5. Defazio RA, Zhao W, Deng X, Obenaus A, Ginsberg MD. Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study. J Cereb Blood Flow Metab. 2012;32(11):2012-22. doi: 10.1038/jcbfm.2012.102 PMID: 22781334; PubMed Central PMCID: PMC3493990.
6. Nimmagadda A, Park HP, Prado R, Ginsberg MD. Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study. Stroke. 2008;39(1):198-204. Epub 2007/11/23. STROKEAHA.107.495598 [pii] doi: 10.1161/STROKEAHA.107.495598 PMID: 18032741; PubMed Central PMCID: PMC2699114.
7. Park HP, Nimmagadda A, DeFazio RA, Busto R, Prado R, Ginsberg MD. Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study. Stroke. 2008;39(5):1556-62. Epub 2008/03/08. STROKEAHA. 107.502195 [pii] doi: 10.1161/STROKEAHA.107.502195 PMID: 18323493; PubMed Central PMCID: PMC2699112.
8. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS phase I trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke. Stroke. 2005;36(2):420-. PMID: WOS:000227523800014.
9. Hill MD, Moy CS, Palesch YY, Martin R, Dillon CR, Waldman BD, et al. The albumin in acute stroke trial (ALIAS); design and methodology. Int J Stroke. 2007;2(3):214-9. Epub 2008/08/19. doi: 10.1111/j. 1747-4949.2007.00143.x PMID: 18705947.
10. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-I: Physiological responses and safety results. Stroke. 2006;37(8):2100-6. Epub 2006/07/01. doi: 10.1161/01. STR.0000231388.72646.05 PMID: 16809571.
11. Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke. 2011;42(1):119-27. doi: 10.1161/STROKEAHA.110.596072 PMID: 21164127; PubMed Central PMCID: PMC3076742.
12. Hill MD, Martin RH, Palesch YY, Tamariz D, Waldman BD, Ryckborst KJ, et al. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke. 2011;42(6):1621-5. Epub 2011/05/07. doi: 10.1161/STROKEAHA.110.610980 PMID: 21546491; PubMed Central PMCID: PMC3118599.
13. Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, et al. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013;12(11):1049-58. Epub 2013/10/01. doi: 10.1016/S1474-4422 (13) 70223-0 PMID: 24076337; PubMed Central PMCID: PMC3929943.
14. Katsanos AH, Korantzopoulos P, Tsivgoulis G, Kyritsis AP, Kosmidou M, Giannopoulos S. Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions. Int J Cardiol. 2013;167(2):328-34. doi: 10.1016/j.ijcard.2012.06.107 PMID: 22809542.
15. Anders B, Alonso A, Artemis D, Schafer A, Ebert A, Kablau M, et al. What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients? Cerebrovascular diseases. 2013;36(3):211-7. doi: 10.1159/000353875 PMID: 24135532.
16. Kral M, Sanak D, Veverka T, Hutyra M, Vindis D, Kuncarova A, et al. Troponin T in acute ischemic stroke. The American journal of cardiology. 2013;112(1):117-21. doi: 10.1016/j.amjcard.2013.02.067 PMID: 23566538.
17. Jensen JK, Ueland T, Aukrust P, Antonsen L, Kristensen SR, Januzzi JL, et al. Highly sensitive troponin T in patients with acute ischemic stroke. European neurology. 2012;68(5):287-93. doi: 10.1159/000341340 PMID: 23051820.
18. Beaulieu-Boire I, Leblanc N, Berger L, Boulanger JM. Troponin elevation predicts atrial fibrillation in patients with stroke or transient ischemic attack. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association. 2013;22(7):978-83. doi: 10.1016/j.jstrokecerebrovasdis. 2012.01.008 PMID: 22341670.
19. Song HS, Back JH, Jin DK, Chung PW, Moon HS, Suh BC, et al. Cardiac troponin T elevation after stroke: relationships between elevated serum troponin T, stroke location, and prognosis. Journal of clinical neurology. 2008;4(2):75-83. doi: 10.3988/jcn. 2008.4.2.75 PMID: 19513307; PubMed Central PMCID: PMC2686869.
20. Blackshear JL, Cutlip DE, Roubin GS, Hill MD, Leimgruber PP, Begg RJ, et al. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation. 2011;123(22):2571-8. Epub 2011/05/25. doi: 10.1161/CIRCULATIONAHA.110.008250 PMID: 21606394; PubMed Central PMCID: PMC3173718.
21. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, et al. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke; a journal of cerebral circulation. 2010;41(1):48-53. doi: 10.1161/STROKEAHA.109.561712 PMID: 19959538.
22. Ginsberg MD, Martin RH, Hill MD, Palesch YY, Yeatts S, Moy CS, et al. The Albumin in Acute Stroke (ALIAS) Trial: Part 1 Safety Analysis. Stroke. 2010;41(4):E228-E. PMID: WOS:000276106100163.
23. Weimar C, Ali M, Lees KR, Bluhmki E, Donnan GA, Diener HC, et al. The Virtual International Stroke Trials Archive (VISTA): results and impact on future stroke trials and management of stroke patients. Int J Stroke. 2010;5(2):103-9. doi: 10.1111/j.1747-4949.2010.00414.x PMID: 20446944.
24. Belayev L, Saul I, Busto R, Danielyan K, Vigdorchik A, Khoutorova L, et al. Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. Stroke. 2005;36(2):326-31. doi: 10.1161/01. STR.0000152949.31366.3d PMID: 15637329.
25. Skhirtladze K, Base EM, Lassnigg A, Kaider A, Linke S, Dworschak M, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. British journal of anaesthesia. 2014;112(2):255-64. doi: 10.1093/bja/aet348 PMID: 24169821.
26. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta anaesthesiologica Scandinavica. 2005;49(8):1163-71. doi: 10. 1111/j.1399-6576.2005.00733.x PMID: 16095459.
27. Hanna J, Winstedt D, Schott U. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy. Scandinavian journal of clinical and laboratory investigation. 2013;73(7):553-62. doi: 10. 3109/00365513.2013.821710 PMID: 24004348.
28. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29. Epub 2008/09/26. doi: 10.1056/NEJMoa0804656 PMID: 18815396.